Mohammad Seyedabadi

6PUBLICATIONS
14CO-AUTHORS
NanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Environmental biogeochemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 08, 2026
Vanillic Acid-Loaded Niosomes for Diabetic Wound Healing: Formulation, Optimization by Box-Behnken Design, and In Vivo Evaluation.

Shervin Amirkhanloo, Reza Enayatifard, Jafar Akbari

|Dec 25, 2025
Microfluidic techniques in the development of PLGA nanoparticles: a tri-combination therapy for paraquat-induced cytotoxicity.

Sajjad Sadeghi, Mohammad Karami, Hamid Madanchi

|Dec 21, 2025
Cardiac-Targeted Quercetin-Loaded PLGA Nanoparticles Attenuate Doxorubicin-Induced Cardiotoxicity via Nrf2/HO-1 Pathway Activation in Mice.

Milad Chahardori, Rezvan Yazdian-Robati, Mohammad Seyedabadi

|Nov 07, 2024
Synergistic effect of curcumin and Piperine loaded Niosomal nanoparticles on acute pulmonary toxicity induced by Paraquat in mice.

Aram Khederzadeh, Pedram Ebrahimnejad, Mohammad Seyedabadi

|Feb 09, 2021
Receptor-Arrestin Interactions: The GPCR Perspective.

Mohammad Seyedabadi, Mehdi Gharghabi, Eugenia V Gurevich

|Oct 22, 2020
Low-dose angiotensin AT1 receptor β-arrestin-biased ligand, TRV027, protects against cisplatin-induced nephrotoxicity.

Abdolhamid Esmaeeli, Fatemeh Ebrahimi, Kaveh Tanha

Pageof 1

Frequent Collaborators

3 joint publications

Hamidreza Mohammadi

1 joint publications

Vsevolod V Gurevich

1 joint publications

Aram Khederzadeh

1 joint publications

Pedram Ebrahimnejad